Managers
Forma Holdings (Forma), an international diversified cannabis company co-founded by Kingsley Capital Partners which operates in legalised, medicinal cannabis markets, has completed its first asset acquisitions and launched its second capital raise, targeting at least GBP10 million for expansion.
This follows the success of a fund raising earlier this year, the proceeds of which were used to acquire Forma’s initial US assets in the Southwestern United States.
This latest fund-raise will harness the rapidly growing interest in the US & Europe in the medical cannabis sector. Proceeds will be used to invest in growing the business and expanding in
Inflexion Private Equity has held the first and final close of Inflexion Enterprise Fund IV and Inflexion Supplemental Fund IV, securing commitments of GBP250 million for each new fund.
Raised exclusively from Inflexion’s existing LP base of blue chip investors from across Europe, the US and Asia, both funds reached their respective hard caps in a single closing, within just eight weeks of launch. In keeping with previous fundraisings, Inflexion closed on timetable and without the support of a placement agent.
Inflexion Enterprise Fund IV, the fourth generation of Inflexion funds focused on the UK lower mid-market, will follow
Funds advised by CVC Capital Partners (CVC) are to acquire 100 per cent of ÅR Packaging Group AB (AR Packaging) from Ahlstrom Capital and Accent Equity.
Founded in 2011 through the merger of A&R Carton and Flextrus, AR Packaging is one of Europe’s leading packaging companies with sales of approximately EUR560 million (pro forma 2015) and 2,200 employees across 17 factories in 9 countries. The company has performed strongly in recent years, posting a 27 per cent increase in net sales last year.
Headquartered in Lund, Sweden, the group is divided into three divisions: Branded Products, Barrier Packaging and Food
Baltic private equity house BaltCap has acquired a majority stake in the leading Estonian occupational health care company Qvalitas Arstikeskus AS (Qvalitas).
BaltCap Private Equity Fund II (BPEF II) signed an agreement to acquire 72 per cent of Qvalitas. The remaining 28 per cent are held by the management team. In addition to BPEF II, Erki Mölder, the CEO of Unimed Group is an investor in the holding company carrying out the transaction.
Qvalitas was founded in 1996 and it offers occupational heath care as well as general and specialised medical services in Estonia. The company is mainly known
The Standard Life European Private Equity Trust (SLEPET) has reported net asset value (NAV) total return for the six months to 31 March 2016 of 11.3 per cent. NAV total return for the 12 months to 31 March 2016 was 17.4 per cent.
The NAV at 31 March 2016 rose 10.2 per cent to 310.2p (30 September 2015; 281.6p) including the payment of a final dividend of 3.5p per ordinary share for the year ended 30 September 2015 in the period.
The Board has declared an interim dividend of 1.80p to be paid on 15 July 2016. It remains
Aleva Neurotherapeutics, a developer of next-generation implants for deep brain stimulation (DBS) in major neurological indications such as Parkinson’s Disease and Essential Tremor, has raised USD 18 million in a Series C financing round.
The round was led by Greatbatch (NYSE:GB), a strategic lead investor contributing a total of USD5 million to the transaction. In February 2016, Aleva and Greatbatch announced the closing of a strategic development, supply and manufacturing agreement. In addition, Aleva will combine their innovative directional lead technology with the proprietary neurostimulation platform of Nuvectra, a recent spin-off from Greatbatch.
Aleva’s existing investors (BioMedPartners, BB Biotech Ventures,
Mid-market private equity firm LDC has backed the GBP22m management buyout of global ID cards business, Magicard, from listed defence and security group Ultra Electronics Holdings plc.
Founded in 1992, Magicard is one of the world’s leading manufacturers of secure desktop ID card printers, software and related consumables for the identity and access control markets. Its products, which include direct-to-card and retransfer printers, are capable of printing and encoding all types of card format, including magnetic stripe, proximity cards and ‘chip and pin’ cards used in the banking sector. Magicard printers are renowned for their built-in card security features, including
Amulet Capital Partners (Amulet), a middle-market private equity investment firm focused exclusively on the healthcare sector, has acquired SynteractHCR Holdings Corporation (SynteractHCR), a contract research organisation (CRO) focused on Phase I‐IV clinical trials for emerging to mid-sized biopharma clients in the US, Europe and Asia.
Terms of the transaction have not been disclosed.
Headquartered outside San Diego, California, SynteractHCR was founded in 1995 and is now a top 20 global full‐service CRO. The company has over 800 staff members across 21 countries. SynteractHCR has a reputation for clinical excellence in complex trials in a broad range of therapeutic areas, contributing
State Street Corporation’s (STT) GX Private Equity Index, a benchmark for comparative analysis of private equity performance, which includes a comprehensive data set dating back to 1980, saw an overall return of 1.11 per cent in Q4 2015.
“Private equity funds posted a modest recovery in the fourth quarter after a brief drop in the previous quarter,” says Will Kinlaw, senior managing director and global head of State Street Associates, part of State Street Global Exchange. “Overall we have seen relatively steady performance in private equity investments for the past few years. The biggest driver in the fourth quarter rebound
Norsk Titanium AS, a supplier of aerospace-grade, additive manufactured, structural titanium components, has closed a USD10 million growth debt facility with Harbert European Growth Capital Fund I (HEGCF) as part of the company’s current aerospace production financing round.
The funds will be used to further strengthen Norsk Titanium’s leadership team and operations worldwide in support of aerospace qualification and production orders for precision structural components produced by the company’s patented Rapid Plasma Deposition (RPD) technology. The investment was led by Fahad Khan at HEGCF. Details of the investment were not released.
“Norsk Titanium is strategically expanding, and the addition of
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
